.png){kind=icon}
返回
Thyroid cancer
.png){kind=icon}
PRE
AI
DOI：10.1016/S0140-6736(23)00020-X.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
The past 5-10 years have brought in a new era in the care of patients with thyroid cancer, with the introduction of transformative diagnostic and management options. Several international ultrasound-based thyroid nodule risk stratification systems have been developed with the goal of reducing unnecessary biopsies. Less invasive alternatives to surgery for low-risk thyroid cancer, such as active surveillance and minimally invasive interventions, are being explored. New systemic therapies are now available for patients with advanced thyroid cancer. However, in the setting of these advances, disparities exist in the diagnosis and management of thyroid cancer. As new management options are becoming available for thyroid cancer, it is essential to support population-based studies and randomised clinical trials that will inform evidence-based clinical practice guidelines on the management of thyroid cancer, and to include diverse patient populations in research to better understand and subsequently address existing barriers to equitable thyroid cancer care.
Keyword:
ASSOCIATION GUIDELINES
SOCIOECONOMIC-STATUS
UNITED-STATES
RADIOFREQUENCY ABLATION
DOUBLE-BLIND
AMERICAN ASSOCIATION
RADIOACTIVE IODINE
ECONOMIC OUTCOMES
NATURAL-HISTORY
CLINICAL-TRIALS
期刊
IF:
88.5
论文数:
5.4W
被引数:
34.8W
机构
引用论文
Understanding Pathways to the Diagnosis of Thyroid Cancer: Are There Ways We Can Reduce Over-Diagnosis?.png)
THYROID
THYROIDIF6.7
PREAI
分享收藏Treatment and Survival Vary by Race/Ethnicity in Patients With Anaplastic Thyroid CancerCANCER
OAAI
CANCERIF5.1
OAAI分享收藏
查看更多内容